Kidney Research and Clinical Practice
Prognostic stratification in a diabetic kidney disease trial using plasma concentrations of soluble tumor necrosis factor receptor 1
Trial in peopleBiomarkers
Papers by Andrzej S. Królewski
2 results
- ADA Scientific Sessions 2025 Abstract
Blocking Neuroblastoma Suppressor of Tumorigenicity 1 (NBL1) Prevents Diabetic Kidney Disease
Experiments in animalsInterventions